Of note, CSF PCSK9 correlated with CSF tau protein, suggesting that PCSK9 may influence tau metabolism and neurofibrillary tangles accumulation rather than amyloid plaques deposition, at least in the pre-symptomatic phase of late-onset AD (Picard et al., 2019). The gene discussed is MAPT; the disease is Alzheimer disease.